Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus

Noriko Ihana-Sugiyama; Ritsuko Yamamoto-Honda; Takehiro Sugiyama; Tetsuro Tsujimoto; Masafumi Kakei; Mitsuhiko Noda

doi:10.12659/MSMBR.902218

28 February 2017 : Clinical Research

Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus

Noriko Ihana-Sugiyama^1ABCDEF, Ritsuko Yamamoto-Honda^12ACDEF, Takehiro Sugiyama^3CDE, Tetsuro Tsujimoto^1D, Masafumi Kakei^4CDE, Mitsuhiko Noda^5ADE*

DOI: 10.12659/MSMBR.902218

Med Sci Monit Basic Res 2017; 23:36-44

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

Export

Export Article Citation

Share via email

Share method:

Via email client program

Send me to my email

Content:

Title, authors, link

Title, authors, link, abstract

Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus

Export

Export Article Citation

Export file: The selected type of file is required

Content:

Share via email

Share method:

Content:

Preview:

Your Privacy